The U.S. Food and Drug Administration has granted CenterVue 510(k) clearance for its next-generation Macular Integrity Assessment device, according to a company press release.The Macular Integrity Assessment (MAIA) for scanning laser ophthalmoscopy confocal microperimetry now features a more ergonomic design and smaller footprint, as well as a more powerful PC, according to the release. Additionally, the redesign allows for faster examinations and includes automatic alignment and dynamic multifixation.